key: cord-0427321-swvxjmsv authors: Akin-Sari, Burcin; Inozu, Mujgan; Haciomeroglu, A. Bikem; Trak, Ezgi; Tufan, Damla; Doron, Guy title: The daily use of a training using a mobile app as a coping tool against COVID-19 distress: A crossover randomized controlled trial date: 2022-05-27 journal: nan DOI: 10.1016/j.jad.2022.05.118 sha: 8e0b7114673181904cbc21374d6c70638d3c18c5 doc_id: 427321 cord_uid: swvxjmsv Background The COVID-19 pandemic has been suggested to constitute a broad base stressor with severe mental health consequences. mHealth applications are accessible self-help tools that can be used to reduce psychological distress during the pandemic. This randomized controlled trial evaluated the effects of mobile-based cognitive training exercises on COVID-19 related distress and maladaptive cognitions. Methods Following initial screening (n = 924), participants scoring 1 standard deviations above the mean of the COVID-19 Distress Scale were randomized into two groups. Participants in the immediate-app group (iApp; n = 25) started using the application at baseline (T0) for 12 days (from T0 to T1). Participants in the delayed-app group (dApp; n = 22) started using the mobile application at T1 (crossover) and used it for the following 12 days (T1 to T2). Results Intention to treat analyses indicated that the iApp group exhibited lower COVID-19 distress, lower depression, fewer intolerance of uncertainty and obsessive beliefs than the dApp group at T1. In addition, using the app for 12 consecutive days was associated with large effect-size reductions (Cohen's d ranging from 0.81 to 2.35) in COVID-19 distress and related maladaptive cognitions in the iApp group (from T0 to T1) and the dApp group (from T1 to T2). Moreover, these reductions were maintained at the follow-up. Limitations This study was a crossover trial with a relatively limited sample size and mainly female participants. Conclusion Our findings underscore the usefulness of brief, low-intensity, portable interventions in alleviating the negative effects of the pandemic on mental health. The Coronavirus disease emerged in China in December 2019 and had a globally devastating impact. Data from January 2022 suggest about 520 million confirmed cases of COVID-19, including more than 6 million deaths (WHO, 2022) . Waves of new COVID-19 variants have governments across the world implementing rigid health safety practices including lockdowns, strict social distancing practices, and quarantine (Murphy et al., 2020) . The COVID-19 pandemic has been associated with significant challenges in the fields of education, health, and the economy (Bambra et al., 2020; Daniel, 2020) . The social, health and economic challenges associated with the COVID-19 pandemic have, therefore, been suggested to constitute a broad base stressor with severe mental health consequences (Cao et al., 2020; Wang et al., 2020; Xiang et al., 2020; Zvolensky et al., 2020) . Indeed, up to 13.6% of US adults reported serious psychological distress in April 2020 (McGinty et al., 2020) . This is a significant increase from the 3.9% of adults reporting such distress in 2018. Similarly, the estimated depression rate in 2021 has increased seven-fold when compared to depression rates reported in 2017 (Bueno-Notivol et al., 2021) . Consistent with this, a recent study has shown that people in 2020 report feeling five times more hopeless during the pandemic than in pre-pandemic periods (Twenge and Joiner, 2020) . Increased levels of COVID-19 related distress have been linked with persistent emotional distress (Vintila et al., 2022) , higher rates of psychopathology (Megalakaki et al., 2021) , greater mental healthcare utilization (Roy et al., 2020) , decreased quality of life (Khodami et al., 2021) , and increased interference in functioning (Gallagher et al., 2020) compared with the general population. Fewer still have been shown to reduce COVID-19 related distress (e.g., Gordon et al., 2021; Mira et al., 2020; Moulaei et al., 2021; Sun et al., 2021) . One mobile mental health platform with relatively robust empirical support including 6 published randomized controlled trials (RCTs) is GGtude (Aboody et al., 2020; Akin-Sari et al., 2022; Ben-Zeev et al., 2021; Cerea et al., 2020; Cerea et al., 2021; Roncero et al., 2019) . GGtude is a CBT-based mobile application platform comprising distinct modules targeting maladaptive beliefs associated with various psychological difficulties (e.g., OCD, depression, low selfesteem, body image distress). The 'GGcov' module assessed in this study is included in an app named: 'GG OCD, anxiety and depression'. This module was designed to challenge beliefs (e.g., likelihood and awfulness of illness) and meta-beliefs (e.g., belief that thinking in certain way can prevent or cause illness) associated with COVID-19 related distress. Users of this module progressively complete a three levels a day. Each daily practice includes 3-4 min of training (see The Several elements of the GGtude platform have been theorized to be implicated in the reduction of users' maladaptive cognitions and associated symptoms (Aboody et al., 2020; Been-Zeev et al., 2021; Giraldo-O'Meara and Doron, 2021; Roncero et al., 2018 Roncero et al., , 2019 . These include 1) psychoeducation to increase users' motivation and provide knowledge of basic CBT principles, 2) researchers then contacted via telephone or e-mail 86 participants who scored at least 1 SD above the mean CDS score (see Figure 1 ), starting with the participant showing the highest scores. Only the participants who could be reached, agree to participate, had a smart mobile phone, and access the internet were included in the study. Forty-seven participants met these inclusion criteria and were randomly assigned to iApp and dApp groups. The iApp group consisted of 25 participants, and the dApp group included 22 participants (see Figure 1 ). To evaluate the efficacy of the app in reducing COVID-19 distress and related psychological outcomes, we conducted a randomized controlled trial with a crossover design (see Figure 2 ). The iApp group began to use the app at T0 and continued to use it for the following 12 days (until T1). The dApp group on the waiting list started to use the app at T1 and used it for the next 12 days (until T2). After obtaining informed consent form, both groups completed self-report questionnaires at T0, T1, and T2. Participants completed the demographic information form at T0 and all other measures at T0, T1, and T2. The CDS is a 14-item self-report measure assessing COVID-19 related distress. Items are rated on a 5-point Likert scale. Examples of scale items include: "I think that any minor health issue I experience is due to the coronavirus.", "I believe that people in my immediate circle are very likely to become infected with the coronavirus." or "I constantly read coronavirus-related content on the internet / social media.". Higher scores indicate greater pandemic-related distress. The CDS demonstrated robust psychometric properties in a community sample of adults. In a study with 548 individuals, exploratory factor analysis suggested a three-factor structure including anxiety, threat perception, and hopelessness related to COVID-19. In another study with 626 individuals, the 3factor model obtained in the exploratory factor analysis was tested with confirmatory factor analysis. Results of the confirmatory factor analysis indicated a good fit to the data: χ2/df = 2.917, CFI = .94, NFI = .92, RFI = .90, IFI = .95, TLI = .93, RMSEA = .057 (90% confidence interval: 0.050−0.064), SRMR = 0.060. The CDS scores were positively associated with general distress, health anxiety, and obsessivecompulsive tendencies, while they were negatively related to resilience and positive affect. In addition, CDS scores significantly predicted general distress and health anxiety over and above other mental health measures. The CDS had a Cronbach's alpha score of .87 and test-retest reliability of .79 over two weeks (N = 249). Cronbach's alpha values were .90 for the screening study (N = 924), .79 at T0, .92 at T1 and .91 at T2 (N = 46). Scale-21 (DASS-21; Lovibond and Lovibond, 1995) DASS-21 is a self-report measure consisting of three 7-item scales assessing depression, anxiety, and stress. Items are rated on a 4-point Likert scale, and higher scores indicate higher levels PHQ-9 is a self-report measure assessing depression. The scale has 9 items rated on a 4points Likert scale, and higher scores indicate higher depressive symptoms. The original version and the Turkish adaptation of PHQ-9 demonstrated excellent psychometric properties (Gulec et al., 2012; Kroenke et al.,2001) . In the present study, the scale had a Cronbach's alpha value of 0.82 at T0, 0.86 at T1, and 0.85 at T2 (N = 46). (IUS; Carleton et al., 2007) IUS is a 12-item self-report measure assessing the intolerance regarding the uncertainty of the occurrence of adverse events. Items are rated on a 5-point Likert scale, and higher scores correspond to greater intolerance of uncertainty. IUS has good psychometric qualities (Carleton et al., 2007) . IUS's Turkish adaptation also has adequate validity and reliability (Saricam et al., 2014) . The Cronbach's alpha value for the scale was 0.91 at T0, 0.93 at T1, and 0.94 at T2 (N = 46) in the current study. OBQ is a 44-item self-report measure assessing beliefs and appraisals related to obsessivecompulsive disorder. Items are rated on a 7-point Likert scale. OBQ has three subscales: responsibility and overestimation of threat, perfectionism, and intolerance of uncertainty, importance, and control of thoughts. The original and Turkish adaptations of the scale demonstrated excellent validity and reliability (OCCWG, 2001 (OCCWG, , 2003 Yorulmaz and Gencoz, 2008) . The Cronbach's alpha value for the total scale score was 0.95 at T0, 0.97 at T1, and 0.97 at T2 (N = 46) in the current study. COVID-19 distress. Users first go through a tutorial consisting of short psychoeducation on the meaning and importance of one's inner monologue, the aim of the mobile application (broaden one's inner monologue), the rationale behind the exercises, and instructions for doing the exercises. After the psychoeducation, users learn to respond to statements that challenge maladaptive beliefs underlying COVID-19 related distress (e.g., intolerance of uncertainty, overestimation of threat, likelihood and awfulness of illness, inadequacy of medical services, catastrophizing of bodily sensations and the body's inability to cope with illness) by swiping the statements down (pulling them towards themselves). In contrast, users learn to reject and dissociate from statements that are consistent with COVID-19 related maladaptive beliefs by swiping the statements up (pushing them away from themselves). In this way, the app trains users to identify and challenge negative cognitions and maladaptive beliefs related to COVID-19 related distress and expands users' functional inner monologue by providing self-statements associated with adaptive attitudes. Participants using GGcov were asked to complete three levels per day (about 4-min of training a day) before going to sleep. Push notifications reminded users to complete their daily training each day. Three levels on GGcov make a set dedicated to a specific belief. Each set of beliefs is preempted by a short rationale for challenging this belief. Next, several adaptive or maladaptive sentences appear on the screen one by one. For instance, a level dealing with tolerating uncertainty may include self-statements such as "Feeling uncertain is a natural part of life." and "Uncertainty is unbearable." A level dealing with the likelihood of becoming ill may include self-statements such as "I am as strong as others." and "I am more likely than others to get an illness". Each level completed is followed by a short memory quiz to increase user attention during the training session. All expressions in the application were translated into Turkish by five clinical psychologists who are fluent in English. The suitability of the app to the Turkish language was then assessed in a J o u r n a l P r e -p r o o f Journal Pre-proof pilot study. The sample of the pilot consisted of 20 participants between the ages of 18-35 years. The participants were asked to report the incomprehensible sentences and possible translation errors they noticed during the 12-day use period for the application. A small compensation fee (50 Turkish Liras) was given to the participants for their time. In the randomized controlled trial, iApp and dApp groups responded to an online questionnaire package including a demographic information form, CDS, PHQ-9, DASS-21 Stress Scale, IUS, and OBQ-44 (T0). Then participants were randomized to the iApp or dApp groups. Randomization was carried out in a 1:1 ratio and based on a prespecified computer-generated randomization list generated on Randomizer.org. Group assignment was then performed via email using the next available number on the randomization list. After the assessment at T0, researchers made a 15-minutes video interview with the iApp group participants and informed them about the GGcov app and the intervention. After using the GGcov for 12 days, users in the iApp group responded to all T1 measures. They were then asked to cease using the application for the next 12 days, while the dApp group started using GGcov. The dApp group also completed three levels a day for the next 12 days (until T2). Both groups completed the self-report measures for the third time at T2. Participants were compensated 50 Turkish Liras (approximately 7$) for their participation upon completing the study. The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethical Commission of the [blinded for review purposes] University. The current trial was designed to CONSORT-EHEALTH checklist and registered. We investigated group differences in socio-demographic variables and outcome measures (CDS, DASS-21 Stress Scale, PHQ-9, IUS and OBQ-44) with t-tests and calculated Pearson product moment correlations for study measures at T0. To prevent the potential biased effect of randomized allocation and missing responses, we used an intent-to-treat approach and implemented a multiple imputation strategy to replace missing values (Hollis and Campbell, 1999) . Multiple imputation is J o u r n a l P r e -p r o o f Journal Pre-proof considered a suitable method of handling missing data in repeated measure designs and has been shown to have utility with levels of missing data greater than that observed in this study (Vallejo et al., 2011) . Specifically, we used Multivariate Imputation with Chained Equations (Van Buuren and Groothuis-Oudshoorn, 2011; [MICE] ). Multiple imputation methods follow 3 steps: a) Imputingrepeating over several iterations (i) as opposed to a single imputation. b) Analyzing -after each iteration the dataset completed is analyzed, leading to a distribution of i statistics, 1 per dataset. c) Pooling -the i results are pooled into one estimate. Multiple imputation therefore also has the added benefit of examining the variance in estimates over iterations, reflecting the degree of uncertainty over which value to impute (Lall, 2016). All participants starting a trial were represented with data at each follow-up time point with the Multiple Imputation procedure currently regarded as best practice. We conducted a 2 (Group: iApp, dApp) x 2 (Time: T0 and T1) repeated measures multiple analysis of variance (MANOVA) for five dependent variables to examine the impact of GGcov on outcome measures. We conducted two repeated measures MANOVAs to examine the differences across three time points for each group separately. All statistical analyzes were conducted with IBM SPSS. We compared iApp and dApp groups in terms of gender, age, education (years), CDS, DASS Stress, PHQ-9, IUS and OBQ-44 scores at baseline. Groups did not significantly differ from each other in terms of gender, age, years of education, and self-report measures (see Table 1 ). Pearson product-moment correlation coefficients indicated that individuals with higher levels of COVID-19 related distress also reported higher levels of stress, depression symptoms, intolerance of uncertainty and obsessive beliefs (Table 2) . Since the correlations between the study measures were higher than .30, to decrease the probability of type 1 error, we examined the effectiveness of GGcov in reducing COVID-19 distress, stress, depression, intolerance of uncertainty and obsessive beliefs scores with a 2 (Group: iApp, dApp) x 2 (Time: T0 and T1) repeated-measures MANOVA where group was treated as a betweensubject factor and time was treated as a within-subject factor. We used a Bonferroni-corrected significance level of p < .01 (.05/5 = .01). Table 3 ). These results indicated that participants in the iApp group exhibited lower COVID-19 distress, lower depression symptoms, fewer intolerance of uncertainty beliefs and obsessive beliefs than the participants in dApp group on the second assessment at T1 (see Figure 2 ). We conducted a second 2 (Group: iApp, dApp) x 2 (Time: T1 and T2) repeated-measures MANOVA where group was treated as a between-subject factor and time was treated as a withinsubject factor to examine the effectiveness of GGcov in reducing COVID-19 distress, stress, depression, intolerance of uncertainty and obsessive beliefs in dApp group after using the mobile app. We used a Bonferroni-corrected significance level of p < .01 (.05/5 = .01). Table 4 ). These results indicated that while participants in the dApp group exhibited higher COVID-19 distress, stress level, depression symptoms, and obsessive beliefs than the participants in iApp group at T1, two groups did not significantly differ in terms of these measures at T2 (see Figure 2 ). In the iApp group, we expected pre-post reduction in COVID-19 distress, stress, depression symptoms, intolerance of uncertainty and obsessive beliefs as well as retention of these effects in the follow-up period. Therefore, we examined pre-to-final changes with a repeated-measures MANOVA with Bonferroni corrections between T0, T1 and T2. Mauchly's test of sphericity indicated that the assumption of sphericity was met for all measures. CDS, PHQ-9, IUS and OBQ-44 scores were In the dApp group, we expected that crossover (i.e. use of the app) would be associated with a significant decrease in COVID-19 distress, stress, health anxiety symptoms, intolerance of uncertainty and obsessive beliefs. Thus, we conducted a repeated-measures MANOVA with Bonferroni corrections between T0, T1 and T2. Mauchly's test of sphericity revealed that the assumption of sphericity had been violated for CDS (χ 2 [2] = 7.62, p = .02), IUS (χ 2 [2] = 10.43, p = .01) and OBQ-44 (χ 2 [2] = 10.23, p = .01). Therefore, we reported Greenhouse-Geisser corrected values for these variables. As expected there were no significant differences between T0 and T1 in related measures, within-group differences between T1 and T2 following the crossover revealed significant reductions in the CDS, DASS-21 Stress Scale, PHQ-9 and OBQ-44 scores (see Table 5 ). These findings suggest that while COVID-19 distress, level of stress, depression symptoms, and obsessive beliefs of dApp group did not change significantly from T0 to T1, they exhibited significantly lower COVID-19 distress, lower stress, lower depression symptoms, and fewer obsessive beliefs at T2 than T1. The widespread psychological distress in response to the pandemic has led mental health professionals to seek reliable information resources and effective interventions to reduce COVID-19 related distress (Kondylakis et al., 2020; O'Donnel et al., 2020; Reyes, 2020) . Several advantages of mHealth apps including continuous availability, wide reach and low cost have made mobile delivered interventions a viable option. Building on previous findings supporting the GGtude platform for a variety psychological difficulty (e.g., Aboody Cerea, et al., 2020 Cerea, et al., , 2021 Roncero et al., 2019) , in this study we evaluated the J o u r n a l P r e -p r o o f Journal Pre-proof effectiveness of the COVID-19 stress reduction module of the GGtude platform (GGcov). This is the first RCT study to assess the efficacy of GGcov in a Turkish cohort showing heightened COVID-19 related distress. Consistent with previous findings, we found that using GGcov was associated with reductions in targeted symptoms and cognitions relative to our delayed use comparison group. More specifically, our findings suggest large effect-size decreases in measures of COVID-19 distress, depression, anxiety and stress symptoms in the iApp group (between T0 and T1) that were replicated in the dApp group (following the crossover between T1 and T2). Using GGcov was also associated with significant large effect-size reduction in COVID-19 related beliefs such as intolerance of uncertainty evaluated with IUS, and overestimation of threat and inflated responsibility measured by OBQ-44 in the iApp group (T1 to T2) and following the crossover in the dApp group (T1 to T2). Most of these reductions were maintained at follow-up (T1 to T2). Unexpectedly, following Bonferroni correction the iApp group did not show statistically significant reductions in stress scores compared to the dApp group between T0 and T1. This may have been the result of our limited sample size. Indeed, within-group analyses of the iApp and the dApp group showed large effect size reductions following GGcov use. Although the findings from this randomized controlled study are encouraging, several limitations of the current research should be noted. Our sample size was limited, and our participants were mostly young women. Although being young and a female have been identified as risk factors for psychological distress during the pandemic (e.g., Horesh et al.,2020; Xiong et al., 2020) , our sample may not be representative broader population. In addition, this study did not include an active control group. Future studies may benefit from including a comparison group using another app or using a different module of the same platform. A relatively novel approach towards cognitive modification is called Approach-Avoidance Training (AAT). During AAT, people approach some stimuli with joystick (e.g., by pulling a joystick toward the body in response to low calorie food) and avoid from high calorie food by pushing a joystick away from the body. There are studies showing that such a motor-response training successfully modifies maladaptive cognitive mechanism underlying problematic behaviors (e.g. Mathew, 2019; Stice et al., 2016) . Although the GGcov application seems to benefit from AAT principles as it contains motor responses that include pulling the statements towards themselves or pushing the statements away from themselves, there is no study comparing the effectiveness of GGcov and other mobile applications using the AAT technique. It is recommended to carry out future studies on different motor-response training. J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f How CBT Can Be Protective Against Anxiety Disorders During COVID-19 Era The Development and Usability Assessment of an mHealth Application to Encourage Self-Care in Pregnant Women against COVID-19 Challenges and opportunities for enhanced cognitive behaviour therapy (CBT-E) in light of COVID-19 Coping with covid-19: urgent need for building resilience through cognitive behaviour theraphy Development and initial validation of the obsessive beliefs questionnaire and the interpretation of intrusions inventory Effectiveness of using a meditation app in reducing anxiety and improving well-being during the COVID-19 pandemic: A structured summary of a study protocol for a randomized controlled trial mHealth: a mechanism to deliver more accessible, more effective mental health care A systematic review of videoconference-delivered psychological treatment for anxiety disorders A mindfulness mobile app for traumatized COVID-19 healthcare workers and recovered patients: a response to "The use of digital applications and COVID-19 BodiMojo: Efficacy of a mobile-based intervention in improving body image and selfcompassion among adolescents A novel approach to challenging OCD related beliefs using Study of knowledge, attitude, anxiety & perceived mental healthcare need in Indian population during COVID-19 pandemic Meaning, misinterpretations, and medicine: A cognitivebehavioral approach to understanding health anxiety and hypochondriasis 2020. The nature and treatment of pandemic-related psychological distress The Turkish short version of the intolerance of uncertainty (IUS-12) scale: The study of validity and reliability A Comparative Examionation of Mental Health Services on Training motor responses to food: A novel treatment for obesity targeting implicit processes Mechanisms of change in CBT treatment Development and initial validation of COVID-19 Distress Scale Mental distress among U.S. adults during the COVID-19 pandemic Comparison of modern methods for analyzing repeated measures data with missing values mice: Multivariate imputation by chained equations in R Emotional distress and coping strategies in COVID-19 anxiety Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China World Health Organization, 2022. WHO Coronavirus (COVID-19) Dashboard Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. The Lancet Psychiatry Impact of COVID-19 pandemic on mental health in the general population: A systematic review Psychometric properties of the Turkish version of the Depression Anxiety Stress Scale-21 (DASS-21) AUTHOR STATEMENT Manuscript title: The Daily Use of a Training Using a Mobile App as a Coping Tool Against COVID-19 Distress: A Crossover Randomized Controlled Trial All persons who meet authorship criteria are listed as authors, and all authors certify that they have participated sufficiently in the work to take public responsibility for the content Writing -original draft, Writing -review & editing. Mujgan Inozu: Conceptualization, Methodology, Data curation, Writing -original draft Writing -review & editing. Ezgi Trak: Data collection, Data curation, Writing -original draft, Writing -review & editing. Damla Tufan: Data collection, Data curation, Writing -original draft  We would like to thank the following people for their contribution: Burcu Yıldırım, Şükriye Acar, Yasemin Erol, Güzide Memişçi and Caner Tülek for for data collection